Upcoming submission to provide updates on VITAL clinical trial showing clinical results showing of this, Vitamin D and Omega-3 fatty acids help prevent cancer mortality and myocardial infarction.
The VITamin D and OmegA-3 (VITAL) sample is the largest and most recent to test whether vitamin D or fish oil can effectively prevent cancer or cardiovascular disease. So far the results have been mixed, but they do promise some results, now confirmed by updated (meta) analyzes. The latest VITAL results will be presented at the Annual Meeting of the North American Menopause Society (NAMS) in Chicago, September 25-28, 201
Nearly 26,000 men and women in the United States participated in the nationwide VITAL clinical trial. After more than five years of study and treatment, the results show promising signals for certain results. For example, while the omega-3 (fish oil) fatty acids show only a small but insignificant decrease in the primary cardiovascular endpoint in major CVD events, they are associated with a significant reduction in heart attacks. The greatest benefit of treatment was observed in people with dietary intakes of fish below the average of 1.5 servings per week, but not in those whose intake was above this level. In addition, African Americans appear to be experiencing the greatest risk reduction. The health benefits of heart are now being confirmed by recent meta-analyzes of randomized omega-3 trials.
Similarly, vitamin D supplementation does not reduce significant CVD or overall cancer incidence, but is associated with a statistically significant reduction in overall cancer mortality among those in the process for at least two years. The effect of vitamin D on reducing cancer deaths is also confirmed by the meta-analysis of vitamin D. tested so far.
"The findings model implies a complex balance of benefits and risks for each intervention and indicates the need for additional research for to determine which people can benefit from these supplements, "says Dr. Joan Manson, lead author of the study at Brigham and Women Hospital, a branch of Harvard Medical School.
" With heart disease and cancer representing the most the significant health threats to women "It is imperative that we continue to study the viability of options that prevent these diseases and help women survive," says Dr. Stephanie Faubion, NAMS Medical Director.
Drs. Manson and Faubion are available for interviews before the Annual Meeting.